Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study
Takamatsu, Hiroyuki, Iida, Shinsuke, Shibayamaâ, Hirohiko, Shibayama, Kazuhiro, Yamazaki, Hiroshi, Suzuki, KenshiLanguage:
english
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-020-02825-w
Date:
January, 2020
File:
PDF, 813 KB
english, 2020